"Hemorrhage" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Bleeding or escape of blood from a vessel.
| Descriptor ID |
D006470
|
| MeSH Number(s) |
C23.550.414
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hemorrhage".
Below are MeSH descriptors whose meaning is more specific than "Hemorrhage".
This graph shows the total number of publications written about "Hemorrhage" by people in this website by year, and whether "Hemorrhage" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 2 | 3 |
| 1996 | 1 | 1 | 2 |
| 1998 | 3 | 0 | 3 |
| 2000 | 1 | 1 | 2 |
| 2001 | 1 | 2 | 3 |
| 2003 | 0 | 3 | 3 |
| 2004 | 3 | 4 | 7 |
| 2005 | 1 | 5 | 6 |
| 2007 | 0 | 6 | 6 |
| 2008 | 3 | 1 | 4 |
| 2009 | 5 | 2 | 7 |
| 2010 | 2 | 7 | 9 |
| 2011 | 3 | 4 | 7 |
| 2012 | 3 | 6 | 9 |
| 2013 | 5 | 6 | 11 |
| 2014 | 4 | 5 | 9 |
| 2015 | 5 | 5 | 10 |
| 2016 | 14 | 7 | 21 |
| 2017 | 7 | 5 | 12 |
| 2018 | 6 | 4 | 10 |
| 2019 | 6 | 9 | 15 |
| 2020 | 7 | 6 | 13 |
| 2021 | 6 | 7 | 13 |
| 2022 | 0 | 14 | 14 |
| 2023 | 1 | 14 | 15 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hemorrhage" by people in Profiles.
-
Inflammatory Potential and Risk?Prediction After PCI in High?Bleeding?Risk?Patients. JACC Cardiovasc Interv. 2024 Feb 12; 17(3):356-358.
-
Prognostic impact of peripheral artery disease in patients with and without high bleeding risk undergoing percutaneous coronary intervention. Catheter Cardiovasc Interv. 2024 Feb; 103(3):425-434.
-
Antiplatelet Therapy for Patients Who Have Undergone Revascularization Within the Past Year: Which Agents and for How Long? Med Clin North Am. 2024 May; 108(3):539-551.
-
Dyspnea-Related Ticagrelor Discontinuation After Percutaneous?Coronary Intervention. JACC Cardiovasc Interv. 2023 10 23; 16(20):2514-2524.
-
Bleeding and Ischemic Risks of Ticagrelor?Monotherapy After Coronary?Interventions. J Am Coll Cardiol. 2023 08 22; 82(8):687-700.
-
Impact of Early Hemodynamic Screening on Extremely Preterm Outcomes in a High-Performance Center. Am J Respir Crit Care Med. 2023 08 01; 208(3):290-300.
-
Treatment of Cancer-Associated Thrombosis: Recent Advances, Unmet Needs, and Future Direction. Oncologist. 2023 07 05; 28(7):555-564.
-
Prehospital Hemorrhage Control and Treatment by Clinicians: A Joint Position Statement. Prehosp Emerg Care. 2023; 27(5):544-551.
-
Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium. Circulation. 2023 06 20; 147(25):1933-1944.
-
Ticagrelor with or without aspirin in high-risk patients with anaemia undergoing percutaneous coronary intervention: a subgroup analysis of the TWILIGHT trial. Eur Heart J Cardiovasc Pharmacother. 2023 06 02; 9(4):328-336.